Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
The Journal of Experimental Medicine|September 17, 2003
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosisPia Villa, Paolo Bigini, Tiziana Mennini, et al.Proceedings of the National Academy of Sciences of the United States of America|April 17, 2008
TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injuryEra Taoufik, Edwige Petit, Didier Divoux, et al.Molecular Medicine (Cambridge, Mass.)|December 21, 2010
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damageIsmayil Ahmet, Hyun-Jin Tae, Magdalena Juhaszova, et al.Journal of Clinical Medicine|July 18, 2020
A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular EdemaNoemi Lois, Evie Gardner, Margaret McFarland, et al.Molecular Medicine (Cambridge, Mass.)|October 19, 2013
ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber densityAlbert Dahan, Ann Dunne, Maarten Swartjes, et al.Molecular Medicine (Cambridge, Mass.)|May 25, 2011
A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shockNimesh S A Patel, Kiran K Nandra, Michael Brines, et al.Proceedings of the National Academy of Sciences of the United States of America|January 27, 2005
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injuryFabio Fiordaliso, Stefano Chimenti, Lidia Staszewsky, et al.Journal of Molecular Medicine (Berlin, Germany)|November 7, 2014
Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cellsStefan Bohr, Suraj J Patel, Radovan Vasko, et al.Molecular Medicine (Cambridge, Mass.)|March 15, 2012
Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injuryNimesh S A Patel, Hannah L Kerr-Peterson, Michael Brines, et al.Molecular Medicine (Cambridge, Mass.)|November 12, 2014
ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetesMichael Brines, Ann N Dunne, Monique van Velzen, et al.Pageof 7